Clinical trial
Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG)
NCT00093886 · The Medicines Company, Industry · Completed
Key facts
| NCT number | NCT00093886 |
|---|---|
| Title | Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG) |
| Official title | Evaluation of Clevidipine in the Perioperative Treatment of Hypertension Assessing Safety Events (With Nitroglycerin as Active Comparator) (ECLIPSE-NTG) |
| Acronym | ECLIPSE-NTG |
| Lead sponsor | The Medicines Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | clevidipine, nitroglycerin |
| Enrollment | 629 |
| Start date | Apr 1, 2004 |
| Primary completion | Mar 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | Oct 8, 2004 |
| Last update posted | May 6, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: